Research Square·11 SepAssociation of the PREVENT 10-year ASCVD risk score with left ventricular mass and myocardial mechano-energetic efficiency: a cross-sectional studyPreprint: cross-sectional study of 2,802 peopleBiomarkersPaper
European Journal of Preventive Cardiology·9 SepThe Transition from Stage A to Stage B of Heart Failure: Risk Factors, Promoting Factors, and Opportunities for Prevention-An Update from the Italian Society of Cardiology Working Group on Heart FailureReviewHeart diseasePaper
Internal and Emergency Medicine·26 AugPrescription of SGLT-2 inhibitors alone or in combination with RAS-inhibitors in patients with diabetes mellitus and comorbid cardiovascular disease, chronic kidney disease or cardiorenal disease: a real-world evidence study from the REPOSI registryStudy in peoplePopulationsPaper
Internal and Emergency Medicine·24 AugClinically recognized sepsis in older adults admitted to medical wards: patient characteristics and hospital outcomes from the REPOSI registerCohort study of 8,880 peopleSepsisPaper
Internal and Emergency Medicine·20 AugOral semaglutide vs DPP-4 inhibitors in reducing risk of cognitive impairment in elderly patients with HFpEF and obesityNon-randomised trial in 246 peopleSemaglutidePaper
Cardiac Failure Review·12 AugMultidimensional and Multidisciplinary Management of Heart Failure Patients with FrailtyReviewInterventionsPaper